The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Review of the Diagnosis and Treatment of Periodic Paralysis
Open accessAbstract
Periodic paralyses (PPs) are rare neuromuscular disorders caused by mutations in skeletal muscle sodium, calcium, and potassium channel genes. PPs include hypokalemic paralysis, hyperkalemic paralysis, and Andersen‐Tawil syndrome. Common features of PP include autosomal dominant inheritance, onset typically in the first or second decades, episodic attacks of flaccid weakness, which are often triggered by diet or rest after exercise. Diagnosis is based on the characteristic clinic presentation then confirmed by genetic testing. In the absence of an identified genetic mutation, documented low or high potassium levels during attacks or a decrement on long exercise testing support diagnosis. The treatment approach should include both management of acute attacks and prevention of attacks. Treatments include behavioral interventions directed at avoidance of triggers, modification of potassium levels, diuretics, and carbonic anhydrase inhibitors. Muscle Nerve 57: 522–530, 2018
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plaster, N. M., Tawil, R., Tristani-Firouzi, M., Canún, S., Bendahhou, S., Tsunoda, A., Donaldson, M. R., Iannaccone, S. T., Brunt, E., Barohn, R., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00342-7 · Cited by 995
Self-citationFunctional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)
Tristani-Firouzi, M., Jensen, J. L., Donaldson, M. R., Sansone, V., Meola, G., Hahn, A., Bendahhou, S., Kwiecinski, H., Fidzianska, A., Plaster, N., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15183 · Cited by 561
Self-citationThe primary periodic paralyses: diagnosis, pathogenesis and treatment
Venance, S. L., Cannon, S. C., Fialho, D., Fontaine, B., Hanna, M. G., Ptacek, L. J., Tristani-Firouzi, M., Tawil, R., & Griggs, R. C. (2006) · Brain · doi:10.1093/brain/awh639 · Cited by 370
Self-citationRyan, D. P., Dias da Silva, M. R., Soong, T. W., Fontaine, B., Donaldson, M. R., Kung, A. W. C., Jongjaroenprasert, W., Liang, M. C., Khoo, D. H. C., Cheah, J. S., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.024 · Cited by 311
Self-citationElectromyography guides toward subgroups of mutations in muscle channelopathies
Fournier, E., Arzel, M., Sternberg, D., Vicart, S., Laforet, P., Eymard, B., Willer, J., Tabti, N., & Fontaine, B. (2004) · Annals of Neurology · doi:10.1002/ana.20241 · Cited by 309
Self-citationZhang, L., Benson, D. W., Tristani-Firouzi, M., Ptacek, L. J., Tawil, R., Schwartz, P. J., George, A. L., Horie, M., Andelfinger, G., Snow, G. L., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.472498 · Cited by 282
Self-citationCorrelating phenotype and genotype in the periodic paralyses
Miller, T. M., Dias da Silva, M. R., Miller, H. A., Kwiecinski, H., Mendell, J. R., Tawil, R., McManis, P., Griggs, R. C., Angelini, C., Servidei, S., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000143383.91137.00 · Cited by 260
Self-citationLin, S.-H. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.1.99 · Cited by 254
Lehmann‐Horn, F., Küther, G., Ricker, K., Grafe, P., Ballanyi, K., & Rüdel, R. (1987) · Muscle & Nerve · doi:10.1002/mus.880100414 · Cited by 236
Cannon, S. C., H. Brown, R., & Corey, D. P. (1991) · Neuron · doi:10.1016/0896-6273(91)90064-7 · Cited by 216
Self-citationSternberg, D. (2001) · Brain · doi:10.1093/brain/124.6.1091 · Cited by 214
Channelopathies of Skeletal Muscle Excitability
Cannon, S. C. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140062 · Cited by 212
Self-citationThe exercise test in periodic paralysis
McManis, P. G., Lambert, E. H., & Daube, J. R. (1986) · Muscle & Nerve · doi:10.1002/mus.880090805 · Cited by 204
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis
Matthews, E., Labrum, R., Sweeney, M. G., Sud, R., Haworth, A., Chinnery, P. F., Meola, G., Schorge, S., Kullmann, D. M., Davis, M. B., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000342387.65477.46 · Cited by 201
Self-citationFunctional consequences of a Na+ channel mutation causing hyperkalemic periodic paralysis
Cummins, T. R., Zhou, J., Sigworth, F. J., Ukomadu, C., Stephan, M., Ptáčk, L. J., & Agnew, W. S. (1993) · Neuron · doi:10.1016/0896-6273(93)90168-q · Cited by 177
Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
Imbrici, P., Liantonio, A., Camerino, G. M., Bellis, M. D., Camerino, C., Mele, A., Giustino, A., Pierno, S., Luca, A. D., Tricarico, D., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00121 · Cited by 173
Drug-Induced Renal Calculi: Epidemiology, Prevention and Management
Daudon, M., & Jungers, P. (2004) · Drugs · doi:10.2165/00003495-200464030-00003 · Cited by 161
Randomized trials of dichlorphenamide in the periodic paralyses
Tawil, R., McDermott, M. P., Brown, R., Shapiro, B. C., Ptacek, L. J., McManis, P. G., Dalakas, M. C., Spector, S. A., Mendell, J. R., Hahn, A. F., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1<46::aid-ana9>3.0.co;2-h · Cited by 159
Self-citationTREATMENT OF ATTACKS IN HYPERKALÆMIC FAMILIAL PERIODIC PARALYSIS BY INHALATION OF SALBUTAMOL
Wang, P., & Clausen, T. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91340-4 · Cited by 156
Ahlawat, S. K., & Sachdev, A. (1999) · Postgraduate Medical Journal · doi:10.1136/pgmj.75.882.193 · Cited by 141
Prevalence study of genetically defined skeletal muscle channelopathies in England
Horga, A., Rayan, D. L. R., Matthews, E. L., Sud, R., Fialho, D., Durran, S., Burge, J. A., Portaro, S., Davis, M. B., Haworth, A., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828cf8d0 · Cited by 136
Self-citationAcetazolamide Treatment of Hypokalemic Periodic Paralysis
Griggs, R. C., ENGEL, W. K., & RESNICK, J. S. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-1-39 · Cited by 130
Self-citationVoltage-sensor mutations in channelopathies of skeletal muscle
Cannon, S. C. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.186874 · Cited by 119
Self-citationAcetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype
Matthews, E. L., Portaro, S., Qian, K., Sud, R., Haworth, A., Davis, M. B., Griggs, R. C., & Hanna, M. G. (2011) · Neurology · doi:10.1212/wnl.0b013e31823a0cb6 · Cited by 117
Self-citationAndersen‐Tawil syndrome: Prospective cohort analysis and expansion of the phenotype
Yoon, G., Oberoi, S., Tristani‐Firouzi, M., et al. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31092 · Cited by 111
Fontaine, B. (2008) · Advances in genetics · doi:10.1016/s0065-2660(08)01001-8 · Cited by 105
Self-citationRefined exercise testing can aid dna‐based diagnosis in muscle channelopathies
Tan, S. V., Matthews, E. L., Barber, M., Burge, J. A., Rajakulendran, S., Fialho, D., Sud, R., Haworth, A., Koltzenburg, M., & Hanna, M. G. (2011) · Annals of Neurology · doi:10.1002/ana.22238 · Cited by 103
Self-citationManagement and Treatment of Andersen-Tawil Syndrome (ATS)
Sansone, V., & Tawil, R. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.01.005 · Cited by 102
Self-citationPERMANENT MUSCLE WEAKNESS IN FAMILIAL HYPOKALAEMIC PERIODIC PARALYSIS
Links, T. P., Zwarts, M. J., Wilmink, J. T., Molenaar, W. M., & Oosterhuis, H. J. G. H. (1990) · Brain · doi:10.1093/brain/113.6.1873 · Cited by 98
Exercise test in muscle channelopathies and other muscle disorders
Küntzer, T., Flocard, F., Vial, C., Köhler, A., Magistris, M. R., Labarre‐Vila, A., Gonnaud, P., Ochsner, F., Soichot, P., Chan, V., et al. (2000) · Muscle & Nerve · doi:10.1002/1097-4598(200007)23:7<1089::aid-mus12>3.0.co;2-q · Cited by 95
Tricarico, D., Barbieri, M., Mele, A., Carbonara, G., & Camerino, D. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-0722fje · Cited by 88
Acetazolamide Prophylaxis in Hypokalemic Periodic Paralysis
Resnick, J. S., Engel, W. K., Griggs, R. C., & Stam, A. C. (1968) · New England Journal of Medicine · doi:10.1056/nejm196803142781102 · Cited by 86
Self-citationTreatment for periodic paralysis
Sansone, V., Meola, G., Links, T. P., Panzeri, M., & Rose, M. R. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005045.pub2 · Cited by 83
Self-citationA Kir3.4 mutation causes Andersen–Tawil syndrome by an inhibitory effect on Kir2.1
Kokunai, Y., Nakata, T., Furuta, M., Sakata, S., Kimura, H., Aiba, T., Yoshinaga, M., Osaki, Y., Nakamori, M., Itoh, H., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000239 · Cited by 82
Genotype-Phenotype Correlation and Therapeutic Rationale in Hyperkalemic Periodic Paralysis
Jurkat‐Rott, K., & Lehmann‐Horn, F. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.02.001 · Cited by 80
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis
Sansone, V., Burge, J. A., McDermott, M. P., Smith, P., Herr, B. E., Tawil, R., Pandya, S., Kissel, J. T., Ciafaloni, E., Shieh, P. B., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002416 · Cited by 79
Self-citationMeasuring quality of life impairment in skeletal muscle channelopathies
Sansone, V., Ricci, C., Montanari, M., Apolone, G., Rose, M. R., Meola, G., & INQoL Group (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03751.x · Cited by 78
Self-citationBinder, M. D., Hirokawa, N., & Windhorst, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_6003 · Cited by 78
Bendahhou, S., Cummins, T., Griggs, R. C., Fu, Y., & Ptáček, L. J. (2001) · Annals of Neurology · doi:10.1002/ana.1144 · Cited by 70
Self-citationMatthews, E. L., & Hanna, M. G. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.186627 · Cited by 64
Self-citationIntravenous Treatment of Hypokalemic Periodic Paralysis
Griggs, R. C., Resnick, J. S., & Engel, W. K. (1983) · Archives of Neurology · doi:10.1001/archneur.1983.04050080039005 · Cited by 58
Self-citationTreatment of “permanent” muscle weakness in familial hypokalemic periodic paralysis
Dalakas, M. C., & Engel, W. K. (1983) · Muscle & Nerve · doi:10.1002/mus.880060303 · Cited by 58
Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.
Lehmann‐Horn, F., Jurkat‐Rott, K., & Rüdel, R. (2008) · PubMed · Cited by 56
Acetazolamide‐induced nephrolithiasis: Implications for treatment of neuromuscular disorders
Tawil, R., Moxley, R. T., & Griggs, R. C. (1993) · Neurology · doi:10.1212/wnl.43.6.1105 · Cited by 54
Self-citationCharacterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals
Charles, G. D. B., Zheng, C., Lehmann‐Horn, F., Jurkat‐Rott, K., & Levitt, J. O. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7025-9 · Cited by 50
Hypokalemic periodic paralysis exacerbated by acetazolamide
Torres, C. F., Griggs, R. C., Moxley, R. T., & Bender, A. N. (1981) · Neurology · doi:10.1212/wnl.31.11.1423 · Cited by 49
Self-citationTricarico, D., & Camerino, D. C. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00008 · Cited by 43
Hereditary Channelopathies in Neurology
Jurkat‐Rott, K., Lerche, H., Weber, Y. G., & Lehmann‐Horn, F. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-9485-8_18 · Cited by 40
Bumetanide prevents transient decreases in muscle force in murine hypokalemic periodic paralysis
Wu, F., Mi, W., & Cannon, S. C. (2013) · Neurology · doi:10.1212/wnl.0b013e3182886a0e · Cited by 37
Self-citationBeneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis
Wu, F., Mi, W., & Cannon, S. C. (2013) · Brain · doi:10.1093/brain/awt280 · Cited by 35
Self-citationCavel-Greant, D., Lehmann‐Horn, F., & Jurkat‐Rott, K. (2012) · PubMed Central · Cited by 28
Acetazolamide-induced Muscle Weakness in Hypokalemic Periodic Paralysis.
Ikeda, K., Iwasaki, Y., Kinoshita, M., Yabuki, D., IGARASHI, O., Ichikawa, Y., & Satoyoshi, E. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.743 · Cited by 26
Treatment for periodic paralysis
Sansone, V., Links, T. P., Meola, G., & Rose, M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005045 · Cited by 14
Self-citationAndersen-Tawil syndrome: An ever-expanding phenotype?
Tristani‐Firouzi, M. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.08.015 · Cited by 12
Cited by
Maggi, L., Bonanno, S., Altamura, C., & Desaphy, J.-F. (2021) · Cells · doi:10.3390/cells10061521 · Cited by 51
“ATS is potentially fat l disorder due to the occurrence of ventricular arrhythmia, and early diagnosis is required for proper manag ment [41].”
BackgroundWelland, N. L., Hæstad, H., Fossmo, H. L., Giltvedt, K., Ørstavik, K., & Nordstrøm, M. (2021) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200604 · Cited by 14
Allard, M., Barrallier, M., Pisaroni, H., Fichet, M., De La Vergne De Cerval, M., Pflaum, R., Poisson, A., Derrien, C., Bonnet, F., & Vaduva, P. (2023) · Annales d'Endocrinologie · doi:10.1016/j.ando.2023.01.007 · Cited by 9
Pathophysiologic approach in genetic hypokalemia: An update
Blanchard, A. (2023) · Annales d'Endocrinologie · doi:10.1016/j.ando.2022.11.005 · Cited by 8
Hypokalemic Periodic Paralysis Exacerbated by Carbohydrate Load: A Case Report
Blanton, R., & Afzal, S. (2022) · Cureus · doi:10.7759/cureus.28851 · Cited by 3
Metadata
- Authors
- Statland, J. M., Fontaine, B., Hanna, M. G., Johnson, N. E., Kissel, J. T., Sansone, V. A., Shieh, P. B., Tawil, R. N., Trivedi, J., Cannon, S. C., & Griggs, R. C.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2017-11-29
- Volume
- 57
- Issue
- 4
- Pages
- 522-530
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2767385141
- Cited by
- 273
- References
- 54
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.